S 296

  • Vermont Senate Bill
  • 2019-2020 Regular Session
  • Introduced in Senate Jan 15, 2020
  • Passed Senate Mar 11, 2020
  • House
  • Governor

An act relating to limiting out-of-pocket expenses for prescription insulin drugs

Abstract

Bill Sponsors (9)

Rebecca Balint

     
Cosponsor

Deborah Ingram

     
Cosponsor

Richard McCormack

     
Cosponsor

Alice Nitka

     
Cosponsor

Richard Sears

     
Cosponsor

Less…

     
Cosponsor

Votes


No votes to display

Actions


Mar 13, 2020

House

Referred to the Committee on Health Care

Mar 11, 2020

Senate

Read 3rd time & passed

Senate

Unfinished Business/Third Reading

Mar 10, 2020

Senate

New Business/Third Reading

Feb 28, 2020

Senate

Read second time, reported favorably with recommendation of amendment by Senator Balint for Committee on Finance

Senate

Unfinished Business/Second Reading

Senate

Favorable report with recommendation of amendment by Committee on Finance

Senate

Recommendation of amendment by Committee on Finance agreed to

Senate

3rd reading ordered

Feb 27, 2020

Senate

Favorable report with recommendation of amendment by Committee on Finance

Senate

New Business/Second Reading

Feb 26, 2020

Senate

Entered on Notice Calendar

Senate

Favorable report with recommendation of amendment by Committee on Finance

Jan 15, 2020

Senate

Read 1st time & referred to Committee on Finance

Bill Text

Bill Text Versions Format
As Introduced PDF
Official PDF
Unofficial PDF

Related Documents

Document Format
Committee Meetings HTML
Witness List HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Vermont General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.